Help
Posted Fri, Aug, 09,2013
Published today in Cancer Growth and Metastasis is a new review article by Stefanie Kewitz, Ines Volkmer and Martin S. Staege. Read more about this paper below:
Title
Curcuma Contra Cancer? Curcumin and Hodgkin’s Lymphoma
Abstract
Curcumin, a phytochemical isolated from curcuma plants which are used as coloring ingredient for the preparation of curry powder, has several activities which suggest that it might be an interesting drug for the treatment or prevention of cancer. Curcumin targets different pathways which are involved in the malignant phenotype of tumor cells, including the nuclear factor kappa B (NFKB) pathway. This pathway is deregulated in multiple tumor entities, including Hodgkin’s lymphoma (HL). Indeed, curcumin can inhibit growth of HL cell lines and increases the sensitivity of these cells for cisplatin. In this review we summarize curcumin activities with special focus on possible activities against HL cells.
Click here to learn more about the article, download it and comment
Posted in: Articles Published
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie Davies
It was a pleasure participating as a reviewer for Clinical Medicine Insights: Case Reports. The online access was smooth and very user-friendly. The navigation process for submission of reviewer comments was flawless.Overall, a very pleasant process. The case report that I reviewed was a very interesting one, very well written and with many interesting points for readers.
Facebook Google+ Twitter
Pinterest Tumblr YouTube